×






Financial Analysis Center
×






Financial Analysis Center

search

(contoh: TLKM)




MEDS
Financial Statement summary highlights

Red Flag Shareholder
Within 6 months timeframe: total Sold value compared to average transaction value is 1,875.0x --> heavy shareholder selling, beware of stock overhang!
Foreign holders had been net selling 3 months out of the last 6 months time period

Green Flag Shareholder
There were: 1x monthly occurence of decrease in public holding --> buying activity
Net public holding change within the past 6 months: -0.13%
In the last 6 months: out of 203 million shares bought: 2 million shares came from Foreign holders
Foreign holders had been net buying 3 months out of the last 6 months time period


Red Flag I/S
Multiple quarters of (-) Net Income
Top line decreased by -87.5% in latest Q2 '24 quarter
Current EBITDA -1.3 B insufficient to cover current Interest Exp -0.1 B

Green Flag I/S
Total EBITDA 1.8 B is sufficient to cover Total Interest Exp -0.9 B in the last 7 quarters
6 months Net Loss decreasing -54.0% compared to last year


Red Flag B/S
In the last 4 quarters: 1 occurence of Receivables growing 3.9x of Sales growth

Green Flag B/S
Decreasing DER for 4 consecutive quarters
Current Ratio: 3.9x with an avg of 4.1x over 7 quarters


Red Flag C/F
Negative Operating CF with positive Net Profit --> bad earnings quality

Green Flag C/F


Menunjukkan aliran I/S dari top line hingga bottom line
Menunjukkan breakdown common size I/S
Menunjukkan net flow dana Asing

(in shares)

Menunjukkan breakdown dari Revenues dan Expenses
Menunjukkan pengelompokkan akun neraca

Bubble size is proportional to the value of each Balance Sheet account